Home
Live Updates
Beckman Coulters DxI 9000 Immunoassay Analyzer with Increased Assay Development Sensitivity Makes First North American Appearance at 2023 AACC : comparemela.com
Beckman Coulter's DxI 9000 Immunoassay Analyzer with Increased Assay Development Sensitivity Makes First North American Appearance at 2023 AACC
/PRNewswire/ -- Beckman Coulter, a clinical diagnostics leader, today revealed for the first time in North America the DxI 9000 Access Immunoassay Analyzer,...
Related Keywords
Ireland ,
United States ,
America ,
Beckman Coulter ,
Ray Divilley ,
Prnewswire Beckman Coulter ,
Zivjena Vucetic ,
Mayo University Hospital ,
Beckman Coulter Inc ,
Facebook ,
Danaher Corporation ,
Twitter ,
Scientific Affairs ,
Fujirebio Holdings Inc ,
Linkedin ,
Precisionvision Technology ,
North America ,
Immunoassay Analyzer ,
Chief Medical Officer ,
Senior Vice President ,
Beckman Coulter Diagnostics ,
Vitro Diagnostic ,
Access Family Immunoassay ,
Goki Ishikawa ,
Fujirebio Holdings ,
Daily Maintenance ,
Zerodaily Maintenance ,
Relentlessly Reimagine Healthcare ,
Zone Diagnosis ,
Nc ,
comparemela.com © 2020. All Rights Reserved.